---
title: "Gut Microbiota Links Between Type 2 Diabetes and Atherosclerosis: Mechanisms and Therapeutic Signa"
id: "pubmed-43002339"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43002339"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43002339/"
doi: "10.1007/s11883-026-01485-1"
published_at: "2026-11-09T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Gut Microbiota Links Between Type 2 Diabetes and Atherosclerosis: Mechanisms and Therapeutic Signa
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43002339
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43002339/)
- **DOI:** [10.1007/s11883-026-01485-1](https://doi.org/10.1007%2Fs11883-026-01485-1)
- **Published At:** 2026-11-09T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The review synthesizes mechanistic, translational, and clinical evidence connecting **gut microbiota** (GM) dysbiosis with both **type 2 diabetes (T2D)** and **atherosclerosis**. - Investigators reported pathways that include impaired intestinal barrier integrity leading to metabolic endotoxemia and activation of innate immune signaling (TLR4/NF-κB and inflammasomes). - Data indicated multiple microbial metabolites—**short-chain fatty acids (SCFAs)**, bile acids (BAs), **trimethylamine N-oxide (TMAO)**, phenylacetylglutamine (PAGln), and tryptophan-derived indoles—modulate glucose and lipid metabolism, insulin signaling, endothelial function, and vascular inflammation. - Clinical and translational studies have found associative signals but largely remain observational; the authors noted incomplete causal evidence linking GM changes to hard cardiometabolic outcomes. - A range of microbiota-directed interventions showed metabolic or vascular surrogate improvements in certain studies: dietary change, prebiotics, probiotics, synbiotics, next-generation probiotics, postbiotics, fecal microbiota transplantation (FMT), and microbiota-modulating antidiabetic drugs. - The review stressed heterogeneous responses across strains, populations, and study designs; durable clinical benefit on cardiovascular endpoints was not consistently demonstrated in the available literature. - Authors recommended future work that is function-focused, causally grounded, and includes adequately powered, outcome-driven clinical trials with GM-guided patient stratification. - The source did not report specific randomized trial designs, dosing regimens, sample sizes, or definitive outcome data establishing clinical efficacy of microbiota-directed therapies on major cardiovascular events.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43002339/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43002339%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43002339/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43002339/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43002339/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43002339/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43002339/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43002339%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43002339%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43002339/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43002339/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43002339/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43002339/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43002339/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43002339/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43002339/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43002339/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43002339/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43002339/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43002339/#mesh-terms) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Review Curr Atheroscler Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Curr+Atheroscler+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Curr+Atheroscler+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) . 2026 Nov 9;28(1):114. doi: 10.1007/s11883-026-01485-1. # From Dysbiosis to Vascular Disease: the Gut Microbiota in Type 2 Diabetes and Atherosclerosis [Sabitha Sasidharan Pillai](https://pubmed.ncbi.nlm.nih.gov/?term=Sasidharan+Pillai+S&cauthor_id=43002339)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43002339/#full-view-affiliation-1 "Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA. sabithas99@gmail.com.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43002339/#full-view-affiliation-2 "Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. sabithas99@gmail.com."), [Ambika P Ashraf](https://pubmed.ncbi.nlm.nih.gov/?term=Ashraf+AP&cauthor_id=43002339)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43002339/#full-view-affiliation-3 "Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL, United States of America.") Affiliations Expand ### Affiliations * 1 Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA. sabithas99@gmail.com. * 2 Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. sabithas99@gmail.com. * 3 Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL, United States of America. * PMID: **43002339** * DOI: [ 10.1007/s11883-026-01485-1 ](https://doi.org/10.1007/s11883-026-01485-1) Item in Clipboard Review # From Dysbiosis to Vascular Disease: the Gut Microbiota in Type 2 Diabetes and Atherosclerosis Sabitha Sasidharan Pillai et al. Curr Atheroscler Rep. 2026. Show details Display options Display options Format Abstract PubMed PMID Curr Atheroscler Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Curr+Atheroscler+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Curr+Atheroscler+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) . 2026 Nov 9;28(1):114. doi: 10.1007/s11883-026-01485-1. ### Authors [Sabitha Sasidharan Pillai](https://pubmed.ncbi.nlm.nih.gov/?term=Sasidharan+Pillai+S&cauthor_id=43002339)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43002339/#short-view-affiliation-1 "Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA. sabithas99@gmail.com.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43002339/#short-view-affiliation-2 "Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. sabithas99@gmail.com."), [Ambika P Ashraf](https://pubmed.ncbi.nlm.nih.gov/?term=Ashraf+AP&cauthor_id=43002339)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43002339/#short-view-affiliation-3 "Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL, United States of America.") ### Affiliations * 1 Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA. sabithas99@gmail.com. * 2 Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. sabithas99@gmail.com. * 3 Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL, United States of America. * PMID: **43002339** * DOI: [ 10.1007/s11883-026-01485-1 ](https://doi.org/10.1007/s11883-026-01485-1) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Purpose of review:** Type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) are closely linked chronic disorders and leading causes of morbidity and mortality worldwide. Increasing evidence identifies the gut microbiota (GM), including its microbial genes and metabolites, as potential modifiers of these processes. This narrative review summarizes mechanistic, translational, and clinical evidence linking GM dysbiosis with T2D and atherosclerosis and evaluates microbiota-directed therapeutic strategies. **Recent findings:** Converging mechanistic, translational, and clinical evidence supports GM dysbiosis as a plausible shared contributor to T2D and atherosclerosis through interconnected pathways involving impaired intestinal barrier integrity and metabolic endotoxemia, TLR4/NF-κB- and inflammasome-mediated inflammation, and microbial metabolites, including short-chain fatty acids (SCFAs), bile acids (BAs), trimethylamine N-oxide (TMAO), phenylacetylglutamine (PAGln), and tryptophan-derived indoles. These pathways can influence glucose and lipid metabolism, insulin signaling, immune activation, endothelial function, and vascular inflammation, providing a biological framework linking dysglycemia with increased cardiovascular risk and supporting the GM as a potential therapeutic target. However, the field remains limited by predominantly observational and confounded human data, incomplete causal evidence, and heterogeneous responses to microbiota-directed interventions. Dietary modification, prebiotics, probiotics, synbiotics, next-generation probiotics and postbiotics, fecal microbiota transplantation, and microbiota-modulating antidiabetic therapies have shown signals of benefit on metabolic or vascular surrogate endpoints, but evidence for durable clinical benefit remains limited and inconsistent across strains, populations, and study designs. Future progress in GM manipulation to improve cardiometabolic outcomes will require function-focused, causally grounded research and adequately powered, outcome-driven clinical trials incorporating GM-guided patient stratification. Until such evidence is available, the GM should be viewed as a biologically compelling and promising, but not yet clinically actionable, link between metabolic and atherosclerotic disease. **Keywords:** Atherosclerosis; Gut microbiota; Gut microbiota dysbiosis; Microbial metabolites; Type 2 diabetes. © 2026. The Author(s). [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Prior Publication/Presentation: Part of the contents of this manuscript was published in JCEM ( https://doi.org/10.1210/clinem/dgae499 ) and Diabetes Therapy ( https://doi.org/10.1007/s13300-026-01851-x ) and presented at the Annual Conference of the Endocrine Society on July 14, 2025, in San Francisco, CA, USA. Competing Interests: The authors declare no competing interests. ## References 1. 1. Tripathy M, Swain J, Das S. The association of diabetes and atherosclerosis: understanding the molecular mechanism of the double burden. Curr Med Chem. 2026;33(23):4791–818. - [PubMed](https://pubmed.ncbi.nlm.nih.gov/42316498/) - [DOI](https://doi.org/10.2174/0109298673435173260213113630) 2. 1. Al-Sharify D, Sun J, Edsfeldt A. The changing epidemiology of human type 2 diabetes–associated atherosclerosis: pathophysiological mechanisms and emerging treatment possibilities. J Intern Med. 2026;300(2):131–52. - [PubMed](https://pubmed.ncbi.nlm.nih.gov/42286930/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/13327444/) - [DOI](https://doi.org/10.1111/joim.70118) 3. 1. Chan YH, Ramji DP. Atherosclerosis: Pathogenesis and Key Cellular Processes, Current and Emerging Therapies, Key Challenges, and Future Research Directions. Methods. Methods Mol Biol [Internet]. 2022; 2419:3–19. Available from: 4. 1. Sasidharan Pillai S, Ashraf AP. Gut microbiota and metabolic health: from dysbiosis to therapeutics. Diabetes Ther. 2026;17(4):483–97. - [DOI](https://doi.org/10.1007/s13300-026-01851-x) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/41762381/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/13103032/) 5. 1. Sasidharan Pillai S, Gagnon CA, Foster C, Ashraf AP. Exploring the gut microbiota: key insights into its role in obesity, metabolic syndrome, and type 2 diabetes. J Clin Endocrinol Metab. 2024;109(11):2709–19. - [PubMed](https://pubmed.ncbi.nlm.nih.gov/39040013/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/11479700/) - [DOI](https://doi.org/10.1210/clinem/dgae499) Show all 125 references ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Atherosclerosis* / microbiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Atherosclerosis%2Fmicrobiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Atherosclerosis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Diabetes Mellitus, Type 2* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Diabetes Mellitus, Type 2* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Diabetes Mellitus, Type 2* / microbiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fmicrobiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Dysbiosis* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Dysbiosis%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Dysbiosis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Dysbiosis* / microbiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Dysbiosis%2Fmicrobiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Dysbiosis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Gastrointestinal Microbiome* / physiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gastrointestinal+Microbiome%2Fphysiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gastrointestinal+Microbiome) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43002339/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43002339/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43002339%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43002339/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43002339%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43002339%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43002339/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FO
## Related Clinical Research

- [Macrophage HDAC3 and GDF3 Drive Adipose Inflammation and Metabolic Dysfunction](https://medichelpline.com/clinical-feed/pubmed-42731468.md) (DOI: 10.1016/j.intimp.2026.117385)
- [Visceral adipose tissue mitochondrial substrate use across euglycemia, prediabetes, and T2D](https://medichelpline.com/clinical-feed/pubmed-43013478.md) (DOI: 10.1080/21623945.2026.2751414)
- [Metformin reduces metabolic and oxidative changes in a high-sucrose Drosophila model](https://medichelpline.com/clinical-feed/plos-one-13-metformin-modulates-survival-oxidative-stress-and-gene-expression-in-a-high.md)
- [Amylyx Presents Avexitide Results; MiniMed Launches Tubeless Insulin Pump](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-november-21-2026.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.